BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24828612)

  • 1. Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells.
    Peverelli E; Giardino E; Treppiedi D; Vitali E; Cambiaghi V; Locatelli M; Lasio GB; Spada A; Lania AG; Mantovani G
    Endocrinology; 2014 Aug; 155(8):2932-41. PubMed ID: 24828612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.
    Peverelli E; Giardino E; Mangili F; Treppiedi D; Catalano R; Ferrante E; Sala E; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
    Cancer Lett; 2018 Oct; 435():101-109. PubMed ID: 30098401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.
    Treppiedi D; Mangili F; Giardino E; Catalano R; Locatelli M; Lania AG; Spada A; Arosio M; Calebiro D; Mantovani G; Peverelli E
    Neuroendocrinology; 2020; 110(7-8):642-652. PubMed ID: 31574507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment.
    Peverelli E; Giardino E; Treppiedi D; Catalano R; Mangili F; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
    Int J Cancer; 2018 May; 142(9):1842-1852. PubMed ID: 29226331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours.
    Vitali E; Cambiaghi V; Zerbi A; Carnaghi C; Colombo P; Peverelli E; Spada A; Mantovani G; Lania AG
    Endocr Relat Cancer; 2016 Mar; 23(3):181-90. PubMed ID: 26733502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST
    Treppiedi D; Marra G; Di Muro G; Catalano R; Mangili F; Esposito E; Calebiro D; Arosio M; Peverelli E; Mantovani G
    Front Endocrinol (Lausanne); 2022; 13():892668. PubMed ID: 35992099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.
    Treppiedi D; Di Muro G; Mangili F; Catalano R; Giardino E; Barbieri AM; Locatelli M; Arosio M; Spada A; Peverelli E; Mantovani G
    Mol Cell Endocrinol; 2021 Mar; 524():111159. PubMed ID: 33428965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.
    Mangili F; Treppiedi D; Catalano R; Marra G; Di Muro G; Spada A; Arosio M; Peverelli E; Mantovani G
    Front Endocrinol (Lausanne); 2020; 11():611752. PubMed ID: 33664708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles.
    Coelho MCA; Vasquez ML; Wildemberg LE; Vázquez-Borrego MC; Bitana L; Camacho AHDS; Silva D; Ogino LL; Ventura N; Sánchez-Sánchez R; Chimelli L; Kasuki L; Luque RM; Gadelha MR
    Sci Rep; 2019 Feb; 9(1):1122. PubMed ID: 30718563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation.
    Peverelli E; Giardino E; Vitali E; Treppiedi D; Lania AG; Mantovani G
    Horm Metab Res; 2014 Nov; 46(12):845-53. PubMed ID: 25068602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.
    Peverelli E; Mantovani G; Vitali E; Elli FM; Olgiati L; Ferrero S; Laws ER; Della Mina P; Villa A; Beck-Peccoz P; Spada A; Lania AG
    J Clin Endocrinol Metab; 2012 Mar; 97(3):967-77. PubMed ID: 22259062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization.
    Treppiedi D; Jobin ML; Peverelli E; Giardino E; Sungkaworn T; Zabel U; Arosio M; Spada A; Mantovani G; Calebiro D
    Endocrinology; 2018 Aug; 159(8):2953-2965. PubMed ID: 29931263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2.
    Ferrante E; Pellegrini C; Bondioni S; Peverelli E; Locatelli M; Gelmini P; Luciani P; Peri A; Mantovani G; Bosari S; Beck-Peccoz P; Spada A; Lania A
    Endocr Relat Cancer; 2006 Sep; 13(3):955-62. PubMed ID: 16954443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathway.
    Najib S; Saint-Laurent N; Estève JP; Schulz S; Boutet-Robinet E; Fourmy D; Lättig J; Mollereau C; Pyronnet S; Susini C; Bousquet C
    Mol Cell Biol; 2012 Mar; 32(5):1004-16. PubMed ID: 22203038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
    Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
    PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.
    Vitali E; Piccini S; Trivellin G; Smiroldo V; Lavezzi E; Zerbi A; Pepe G; Lania AG
    Mol Cell Endocrinol; 2021 May; 527():111226. PubMed ID: 33675866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors.
    Mingione A; Verdelli C; Ferrero S; Vaira V; Guarnieri V; Scillitani A; Vicentini L; Balza G; Beretta E; Terranegra A; Vezzoli G; Soldati L; Corbetta S
    J Mol Endocrinol; 2017 Feb; 58(2):91-103. PubMed ID: 27872158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas.
    Ben-Shlomo A; Liu NA; Melmed S
    Pituitary; 2017 Feb; 20(1):93-99. PubMed ID: 27900635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
    Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
    FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
    Lee Y; Kim JM; Lee EJ
    J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.